StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > What would happen

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Dec 20, 2022 2:59pm

90 Views

Post# 35182899

RE:RE:What would happen

They only needed about $250,000 in extra cash per quarter. So I guess based on your logic if they do nothing they could continue on as is, for 25 years not just a couple.

frewil11 wrote: So what they going to do with the 25 million to grow the company or is Tripp and gang gonna just use it to keep paying themselves for another couple years.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals